Suppr超能文献

广泛性骨盆切除术在复发性卵巢腺癌二线细胞减灭术中的应用。

Extended Pelvic Resections as Part of Secondary Cytoreduction for Relapsed Ovarian Adenocarcinoma.

机构信息

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

"I. Cantacuzino" Clinical Hospital, Bucharest, Romania.

出版信息

In Vivo. 2020 Jan-Feb;34(1):397-400. doi: 10.21873/invivo.11787.

Abstract

BACKGROUND/AIM: Ovarian cancer presents an aggressive tumor biology, a significant number of patients experiencing recurrent disease. The aim of this study was to examine the feasibility and effectiveness of secondary debulking surgery for relapsed ovarian cancer.

PATIENTS AND METHODS

Between 2014 and 2018, debulking surgery for relapsed ovarian cancer was performed in 40 cases.

RESULTS

Debulking surgery to no residual disease was achieved in 31 cases; among the remaining cases, an R1 resection was feasible in six cases, while in the remaining three cases an R2 resection was performed. The most commonly performed visceral resections were represented by rectosigmoidian resection, right colon resection, total or partial cystectomy and unilateral or bilateral ureteral resection. The early postoperative morbidity rate was 32.5% while the postoperative mortality rate was 2.5%.

CONCLUSION

Extended pelvic resections are feasible in patients with relapsed ovarian cancer and might be performed with acceptable rates of postoperative complications.

摘要

背景/目的:卵巢癌具有侵袭性的肿瘤生物学特性,相当数量的患者会出现疾病复发。本研究旨在探讨复发性卵巢癌二次肿瘤细胞减灭术的可行性和有效性。

患者与方法

2014 年至 2018 年间,对 40 例复发性卵巢癌患者实施了肿瘤细胞减灭术。

结果

31 例患者达到无残留疾病的肿瘤细胞减灭术;其余病例中,6 例可行 R1 切除术,而另外 3 例则行 R2 切除术。最常进行的内脏切除术包括直肠乙状结肠切除术、右半结肠切除术、全或部分子宫切除术和单侧或双侧输尿管切除术。术后早期并发症发生率为 32.5%,术后死亡率为 2.5%。

结论

对于复发性卵巢癌患者,可进行广泛的盆腔切除术,且术后并发症发生率可接受。

相似文献

2
Upper Abdominal Resections as Part of Tertiary Cytoreduction for Relapsed Ovarian Cancer.
In Vivo. 2020 Jan-Feb;34(1):407-411. doi: 10.21873/invivo.11789.
3
Tertiary Cytoreduction for Recurrent Epithelial Ovarian Cancer: a Multicenter Study in Turkey.
Asian Pac J Cancer Prev. 2016;17(4):1909-15. doi: 10.7314/apjcp.2016.17.4.1909.
4
Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer.
World J Surg Oncol. 2016 Feb 29;14:58. doi: 10.1186/s12957-016-0800-1.
8
Laparoscopic Debulking Surgery in the Management of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.
Int J Gynecol Cancer. 2015 Sep;25(7):1253-7. doi: 10.1097/IGC.0000000000000491.

引用本文的文献

本文引用的文献

1
Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.
Am J Obstet Gynecol. 2019 Dec;221(6):625.e1-625.e14. doi: 10.1016/j.ajog.2019.06.009. Epub 2019 Jun 14.
2
Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:154-160. doi: 10.1016/j.ejogrb.2018.06.036. Epub 2018 Jun 20.
8
Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy.
Gynecol Oncol. 2013 May;129(2):336-40. doi: 10.1016/j.ygyno.2013.01.015. Epub 2013 Jan 26.
10
Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.
Eur J Surg Oncol. 2010 Jun;36(6):583-8. doi: 10.1016/j.ejso.2010.04.012. Epub 2010 May 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验